Explosive Growth in Extremely Severe Obesity (Under the Radar)
April 28, 2025 — Happy headlines late last year told us that obesity recently “dipped” in the U.S., perhaps because of medicines like semaglutide and tirzepatide. Those headlines presented a partial and misleading truth that a new analysis in Lancet Diabetes & Endocrinology explains more fully. Yes, the prevalence of overweight and mild obesity has seemingly plateaued. But this […]